BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32851477)

  • 21. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
    Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer.
    Li H; Li W; Qi C; Zhou L; Wen F; Qu Y; Yu H
    Front Oncol; 2021; 11():726613. PubMed ID: 34760692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis.
    Deng G; Zhang Y; Ke J; Wang Q; Qin H; Li J; Li Z
    J Transl Med; 2021 Nov; 19(1):486. PubMed ID: 34847914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases.
    Rades D; Johannwerner L; Werner EM; Cremers F; Gliemroth J; Yu NY
    Anticancer Res; 2023 Jul; 43(7):3107-3112. PubMed ID: 37351983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planning and delivery of whole brain radiation therapy with simultaneous integrated boost to brain metastases and synchronous limited-field thoracic radiotherapy using helical tomotherapy: a preliminary experience.
    Gupta T; Basu A; Master Z; Jalali R; Munshi A; Sarin R
    Technol Cancer Res Treat; 2009 Feb; 8(1):15-22. PubMed ID: 19166238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated 
Non-small Cell Lung Cancer and Brain Metastases].
    Liu G; Zhang X; Tian C; Xia G; Liu P; Zhang Q; Li X; Zhang H; Qin N; Wang J; Zhang S
    Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):501-7. PubMed ID: 27561798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
    Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
    Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3.
    Yang J; Zhan W; Zhang H; Song T; Jia Y; Xu H; Lin B; Lv S; Liang X
    Medicine (Baltimore); 2017 Oct; 96(40):e7715. PubMed ID: 28984752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
    Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
    J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
    Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
    Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
    Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
    BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study.
    Giaj Levra N; Sicignano G; Fiorentino A; Fersino S; Ricchetti F; Mazzola R; Naccarato S; Ruggieri R; Alongi F
    Radiol Med; 2016 Jan; 121(1):60-9. PubMed ID: 26231251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extra-cerebral Metastasis - An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT).
    Rades D; Nguyen T; Schild SE
    Anticancer Res; 2020 May; 40(5):2841-2845. PubMed ID: 32366432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy.
    Lagerwaard FJ; van der Hoorn EA; Verbakel WF; Haasbeek CJ; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):253-9. PubMed ID: 19577856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
    Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.